Van Hauwermeiren Timothy 4
4 · iTeos Therapeutics, Inc. · Filed Jun 10, 2022
Insider Transaction Report
Form 4
Van Hauwermeiren Timothy
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2022-06-09+17,538→ 17,538 totalExercise: $18.78Exp: 2032-06-09→ Common Stock (17,538 underlying)
Footnotes (1)
- [F1]This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 9, 2023 or (b) the next annual meeting of the Issuer's stockholders.
Signature
/s/ Adi Osovsky, as Attorney-in-Fact|2022-06-10